Green genes from blue greens: challenges and solutions to unlocking the potential of cyanobacteria in drug discovery
Natural Product Reports · 2026 · 43 (2) · 286-300
DOI: 10.1039/d5np00016e ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Natural Product Reports, 2026. Verfasst von Benjamin Philmus und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Oregon State University, Corvallis, OR, 97333, USA. benjamin.philmus@oregonstate.edu. Hauptthemen laut MEDLINE: Biological Products, Cyanobacteria, Drug Discovery. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: NIGMS NIH HHS, NCCIH NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Cyanobacteria are prolific producers of bioactive natural products. In this article, we outline some challenges faced in exploiting cyanobacteria for drug discovery, current solutions, and pathways forward to fully explore them for drug discovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, Oregon State University, Corvallis, OR, 97333, USA. benjamin.philmus@oregonstate.edu.
- Department of Pharmaceutical Sciences, School of Pharmacy & Pharmaceutical Sciences, University of California, Irvine, Irvine, CA, 92617, USA.
- Department of Medicinal Chemistry, Center for Natural Products, Drug Discovery and Development, University of Florida, Gainesville, FL 32610, USA.
- U.S. Department of Energy, Joint Genome Institute, Lawrence Berkeley National Laboratory, One Cyclotron Road, Berkeley, CA 94720, USA.
- Department of Pharmaceutical Sciences, Retzky College of Pharmacy, University of Illinois, Chicago, Chicago, IL 60612, USA.
- Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, and Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA 92092, USA.
ORCID-Profile: Benjamin Philmus, Nicole E Avalon, Yousong Ding, Drew T Doering, Alessandra S Eustáquio, William H Gerwick, Hendrik Luesch, Jimmy Orjala, Shaz Sutherland, Arnaud Taton, Daniel Udwary
Förderung
- NIGMS NIH HHS
- NCCIH NIH HHS
- NCI NIH HHS
- National Center for Complementary and Integrative Health
- Joint Genome Institute
- Division of Cancer Prevention, National Cancer Institute
- National Institute of General Medical Sciences
Zitieren
APA
Philmus, B., Avalon, N. E., Ding, Y., Doering, D. T., Eustáquio, A. S., Gerwick, W. H., Luesch, H., Orjala, J., Sutherland, S., Taton, A., & Udwary, D. (2026). Green genes from blue greens: challenges and solutions to unlocking the potential of cyanobacteria in drug discovery. Natural Product Reports, 43(2), 286-300. https://doi.org/10.1039/d5np00016e
Vancouver
Philmus B, Avalon NE, Ding Y, Doering DT, Eustáquio AS, Gerwick WH, et al. Green genes from blue greens: challenges and solutions to unlocking the potential of cyanobacteria in drug discovery. Natural Product Reports. 2026;43(2):286-300. doi:10.1039/d5np00016e
BibTeX
@article{Philmus2026,
author = {Philmus, Benjamin and Avalon, Nicole E and Ding, Yousong and Doering, Drew T and Eustáquio, Alessandra S and Gerwick, William H and Luesch, Hendrik and Orjala, Jimmy and Sutherland, Shaz and Taton, Arnaud and Udwary, Daniel},
title = {Green genes from blue greens: challenges and solutions to unlocking the potential of cyanobacteria in drug discovery},
journal = {Natural Product Reports},
year = {2026},
volume = {43},
number = {2},
pages = {286--300},
doi = {10.1039/d5np00016e}
}
EUVIMED